InvestorsHub Logo

InternetForumUser

12/15/17 2:30 PM

#320871 RE: epcjmc #320868

That is interesting because Abbvie purchased Stemcentrx for $10.2B

TampaTradr

12/15/17 5:07 PM

#320889 RE: epcjmc #320868

So Garnick is gone.

4OurRetirement

12/15/17 5:18 PM

#320890 RE: epcjmc #320868

Perhaps Abbvie Never "Left The Table", But Couldn't...

negotiate with our old board who could have been trying to go it alone at the stockholders' expense!

Now consider, since Stemcentrx is part of Abbvie:

https://www.abbvie.com/landing/stemcentrx.html

AND, as you pointed out:

Dr. Robert L. Garnick, also known as Rob, Ph.D., (now) serves as Senior Vice President of Regulatory Affairs at Stemcentrx, Inc...

Well, now that PPHM's old BOD's are out of the way, perhaps Abbvie can finalize the deal they were working on before... or perhaps have been working on all along???

Garnick would now be established in his new role and ready to get the IP in to many multiple trials via Abbvie...

Glta StockHOLDERS!